Lisby Steen 4
4 · Y-mAbs Therapeutics, Inc. · Filed Jan 19, 2023
Insider Transaction Report
Form 4
Lisby Steen
Sr VP & CMO
Transactions
- Award
Common stock
2023-01-17+17,800→ 17,800 total - Award
Employee Stock Option (right to buy)
2023-01-17+35,700→ 35,700 totalExercise: $4.70Exp: 2033-01-17→ Common stock (35,700 underlying)
Footnotes (3)
- [F1]Represents 17,800 restricted stock units ("RSUs") granted to the Reporting Person pursuant to the 2018 Equity Incentive Plan of Y-mAbs Therapeutics, Inc. Each RSU represents a contingent right to receive one share of Common Stock on the vesting dates of the RSU. The RSUs vest by 1/3 on each of January 17, 2024, January 17, 2025 and January 17, 2026 subject to the continuing employment of the Reporting Person on each vesting date.
- [F2]Stock options granted to the Reporting Person pursuant to the 2018 Equity Incentive Plan of Y-mAbs Therapeutics, Inc.
- [F3]The stock option shall vest and become exercisable as to 25% of the shares subject to the option on January 17, 2024, and thereafter vests and become exercisable as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting.